Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience | Zendy

Victoria Serpas Higbie | Zendy; Jane E. Rogers | Zendy; Hyunsoo Hwang | Zendy; Wei Qiao | Zendy; Lianchun Xiao | Zendy; Arvind Dasari | Zendy; Kerri Mola-Rudd | Zendy; Van K. Morris | Zendy; Robert A. Wolff | Zendy; Kanwal Raghav | Zendy; Ryan Huey | Zendy; Christine M. Parseghian | Zendy; Jason Willis | Zendy; Scott Kopetz | Zendy; Michael J. Overman | Zendy; Benny Johnson | Zendy

Open Access

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

Author(s) -

Victoria Serpas Higbie,

Jane E. Rogers,

Hyunsoo Hwang,

Wei Qiao,

Lianchun Xiao,

Arvind Dasari,

Kerri Mola-Rudd,

Van K. Morris,

Robert A. Wolff,

Kanwal Raghav,

Ryan Huey,

Christine M. Parseghian,

Jason Willis,

Scott Kopetz,

Michael J. Overman,

Benny Johnson

Publication year - 2022

Publication title -

the oncologist

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.176

H-Index - 164

eISSN - 1549-490X

pISSN - 1083-7159

DOI - 10.1093/oncolo/oyac162

Subject(s) - pembrolizumab , nivolumab , medicine , microsatellite instability , oncology , colorectal cancer , immune checkpoint , cancer , clinical endpoint , cohort , concomitant , blockade , immunotherapy , clinical trial , allele , biochemistry , chemistry , receptor , microsatellite , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research